Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth

Jinyun Chen(Eureka Therapeutics (United States)), Wenlai Zhou(Novartis (United States))
Oncotarget
November 26, 2013
10.18632/oncotarget.1540
Cited by 87

Related Papers

Targeting <i>HSF1</i> sensitizes cancer cells to HSP90 inhibition
|Oncotarget|2013|59
Exosomes for Immunoregulation and Therapeutic Intervention in Cancer
|Journal of Cancer|2016|56
Identification of Mixed Lineage Leukemia 1(MLL1) Protein as a Coactivator of Heat Shock Factor 1(HSF1) Protein in Response to Heat Shock Protein 90 (HSP90) Inhibition
|Journal of Biological Chemistry|2014|14